ROFR and Co-Sale Agreements Now More Frequent in Seed Transactions
.png)

The inclusion of Right of First Refusal (ROFR) and Co-Sale agreements in tandem have been standard in Series A and later-stage equity financings, appearing in over 90% of deals. However, when it comes to Series Seed financings these provisions have historically been less common – a trend that has reversed in recent years.
According to Aumni data, the prevalence of ROFR and Co-Sale agreements in tandem in seed-stage financings has grown from 75% in 2018 to 93% in 2024, more in-line with later stage rounds.
Right of First Refusal (ROFR) is a provision that gives shareholders the right to purchase shares from a selling shareholder before they are offered to external investors. This gives shareholders the opportunity to protect their investment by increasing their ownership and control.
Co-Sale Agreements give shareholders the right to sell a proportionate number shares alongside a majority shareholder under the same terms. This gives existing shareholders access to liquidity in the event of sale.
While ROFR and Co-Sale agreements can introduce complexity in secondary sale negotiations, they can also lead to a more stable cap table. Additionally, the scope and terms of a ROFR are points of negotiation. The types of shares and sales to which the ROFR applies and the time that existing shareholders have to exercise their options are just a few of the considerations that go into a ROFR provision.
As the prevalence of these provisions in seed-stage financings settles over 90%, their impact on external investors entering the early-stage cap tables through the secondary market will be worth watching.
More on Aumni’s Market Insights
Aumni’s Market Insights provides unparalleled data and analysis to help navigate the complexities of venture capital trends with confidence. Explore how our platform can offer the clarity and perspective you need to make smarter, data-driven decisions in 2025.
©2023 JPMorgan Chase & Co. All rights reserved. JPMorgan Chase Bank, N.A. Member FDIC.
This material is not the product of J.P. Morgan’s Research Department. It is not a research report and is not intended as such. This material is provided for informational purposes only and is subject to change without notice. It is not intended as research, a recommendation, advice, offer or solicitation to buy or sell any financial product or service, or to be used in any way for evaluating the merits of participating in any transaction. Please consult your own advisors regarding legal, tax, accounting or any other aspects including suitability implications, for your particular circumstances or transactions. J.P. Morgan and its third-party suppliers disclaim any responsibility or liability whatsoever for the quality, fitness for a particular purpose, non-infringement, accuracy, currency or completeness of the information herein, and for any reliance on, or use of this material in any way. Any information or analysis in this material purporting to convey, summarize, or otherwise rely on data may be based on a sample or normalized set thereof. This material is provided on a confidential basis and may not be reproduced, redistributed or transmitted, in whole or in part, without the prior written consent of J.P. Morgan. Any unauthorized use is strictly prohibited. Any product names, company names and logos mentioned or included herein are trademarks or registered trademarks of their respective owners.
Aumni, Inc. (“Aumni”) is a wholly-owned subsidiary of JPMorgan Chase & Co. Access to the Aumni platform is subject to execution of an applicable platform agreement and order form and access will be granted by J.P. Morgan in its sole discretion. J.P. Morgan is the global brand name for JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide. Aumni does not provide any accounting, regulatory, tax, insurance, investment, or legal advice. The recipient of any information provided by Aumni must make an independent assessment of any legal, credit, tax, insurance, regulatory and accounting issues with its own professional advisors in the context of its particular circumstances. Aumni is neither a broker-dealer nor a member of any exchanges or self-regulatory organizations.
383 Madison Ave, New York, NY 10017